Will Anduril's valuation hit (HIGH) $150B by June 30?

Anduril's key decision-makers (Luckey + exec team, Series H investors) just closed at $61B in mid-May with no announced follow-on round or catalyst; their revealed incentives favor controlled growth and defense-contract execution, not a 2.5x secondary-market spike in 25 days. NPM secondary trading lacks the volume or buyer base to mechanically produce a $150B mark without a new primary round, which has zero procedural runway before June 30. Base rate for any private defense-tech firm doubling valuation in under a month is effectively zero; recent behavior shows stability post-$61B close, not acceleration.

Rules require NPM price >=$150B on any trading day from May 19 to June 30 2026 (specific NPM source only; post-IPO public cap also allowed but irrelevant here). Current Series H valuation is $61B (mid-May 2026) with no primary round, IPO, or secondary activity capable of producing a 2.5x jump in the remaining ~25 days. No plausible rule-based flip event exists before the deadline, so the consensus-priced No side (97.9¢) meets the >=90% certainty bar with no attribution, timing, or evidence gaps.

Market at 3¢ Yes / 97.9¢ No with $19.8k total volume since May 19 shows real (if thin) consensus against $150B jump from $61B in <6 weeks; 1w price drift -0.7pp on Yes is consistent with no upward repricing. Smart-money whales hold only $4 on Yes (negligible stake, not opposing meaningfully). No thin-book red flags or contradictory sibling-bin flow; microstructure supports riding the No consensus to resolution.